Acquisition of Tests for Serological Diagnosis of Malaria Using the ELISA Technique, with Equipment Placement on a Consumption Basis

This tender pertains to the acquisition of tests for the serological diagnosis of malaria utilizing the Enzyme-Linked Immunosorbent Assay (ELISA) technique. It includes the provision and placement of necessary equipment under a consumption-based agreement, which implies that the supplier will provide the equipment without upfront costs, and payment will be made based on the actual usage of the tests. This approach is aimed at ensuring that healthcare facilities have access to essential diagnostic tools without the burden of initial investment. Key requirements for bidders may include demonstrating experience in supplying similar diagnostic tests and equipment, compliance with health regulations, and the ability to provide maintenance and support for the equipment supplied. The tender is likely to be relevant to public health sectors, particularly in regions where malaria is prevalent, and aims to enhance diagnostic capabilities to improve patient outcomes. Interested parties should ensure they meet all specified criteria and prepare to submit their proposals in accordance with the guidelines provided in the tender documentation.

This is a supplies contract in the health and medical services, finance and banking and information and communication technology sectors, with a focus on Infectious Diseases, Laboratory and Investment. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 8,160.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.